Vault-13

PERCEPTIVE ADVISORS LLC

NEW YORK, NY · CIK 1224962 · 13F filing filed 2026-08-14

SEC-registered investment adviser since 2010 · limited liability company

$6.4bn reported value +27.2% vs Q1 2026
102positions
48.9%in top 10
23 new 30 added 26 reduced 13 sold out vs Q1 2026

Options: 1 call positions ($24.1m notional), 6 put positions ($197.2m notional) – listed below, not included above.

Holdings, Q2 2026

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 PRAXIS PRECISION MEDICINES I COM NEW PRAX PRAX 2,035,986 $681.6m10.58% 10.58% UnchangedShares held: Q3 2025 1.6m, Q4 2025 2.0m, Q1 2026 2.0m, Q2 2026 2.0m
2 SPYRE THERAPEUTICS INC COM NEW SYRE SYRE 4,319,496 $383.5m5.95% 5.95% AddedShares held: Q3 2025 1.2m, Q4 2025 3.1m, Q1 2026 3.8m, Q2 2026 4.3m +536.3k +536,271 14.2%
3 CELCUITY INC COM CELC CELC 3,197,200 $334.5m5.19% 5.19% AddedShares held: Q3 2025 3.0m, Q4 2025 3.2m, Q1 2026 3.1m, Q2 2026 3.2m +70.0k +70,000 2.2%
4 ASCENDIS PHARMA A/S ORD SHS ASND ASND 1,163,721 $310.4m4.82% 4.82% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 1.2m
5 RHYTHM PHARMACEUTICALS INC COM RYTM RYTM 2,586,295 $287.2m4.46% 4.46% AddedShares held: Q3 2025 2.4m, Q4 2025 2.5m, Q1 2026 2.4m, Q2 2026 2.6m +212.5k +212,500 8.9%
6 ROIVANT SCIENCES LTD SHS ROIV ROIV 8,085,461 $286.1m4.44% 4.44% ReducedShares held: Q3 2025 7.4m, Q4 2025 8.0m, Q1 2026 8.3m, Q2 2026 8.1m -200.0k -200,000 -2.4%
7 RELAY THERAPEUTICS INC COM RLAY RLAY 14,106,187 $263.9m4.10% 4.10% AddedShares held: Q3 2025 0, Q4 2025 1.9m, Q1 2026 9.8m, Q2 2026 14.1m +4.4m +4,355,046 44.7%
8 TRAVERE THERAPEUTICS INC COM TVTX TVTX 3,752,574 $213.2m3.31% 3.31% ReducedShares held: Q3 2025 3.8m, Q4 2025 4.3m, Q1 2026 4.1m, Q2 2026 3.8m -390.0k -389,977 -9.4%
9 KARDIGAN INC COM KARD KARD 8,200,662 $195.6m3.04% 3.04% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 8.2m
10 NUVALENT INC COM COM 1,580,505 $195.2m3.03% 3.03% UnchangedShares held: Q3 2025 1.6m, Q4 2025 1.7m, Q1 2026 1.6m, Q2 2026 1.6m
11 EDGEWISE THERAPEUTICS INC COM EWTX EWTX 4,373,974 $177.7m2.76% 2.76% ReducedShares held: Q3 2025 3.8m, Q4 2025 4.5m, Q1 2026 4.4m, Q2 2026 4.4m -50.0k -50,000 -1.1%
12 APOGEE THERAPEUTICS INC COM COM 1,308,113 $173.6m2.70% 2.70% ReducedShares held: Q3 2025 1.4m, Q4 2025 2.3m, Q1 2026 1.5m, Q2 2026 1.3m -232.3k -232,271 -15.1%
13 AMYLYX PHARMACEUTICALS INC COM AMLX AMLX 8,334,882 $149.7m2.32% 2.32% AddedShares held: Q3 2025 9.0m, Q4 2025 8.3m, Q1 2026 8.3m, Q2 2026 8.3m +50.0k +50,000 0.6%
14 MEIRAGTX HLDGS PLC COM MGTX MGTX 10,786,658 $145.7m2.26% 2.26% AddedShares held: Q3 2025 12.6m, Q4 2025 10.3m, Q1 2026 10.3m, Q2 2026 10.8m +460.6k +460,555 4.5%
15 ORUKA THERAPEUTICS INC COM ORKA ORKA 1,345,063 $128.0m1.99% 1.99% ReducedShares held: Q3 2025 1.3m, Q4 2025 1.5m, Q1 2026 1.4m, Q2 2026 1.3m -50.4k -50,438 -3.6%
16 INHIBRX BIOSCIENCES INC COM INBX INBX 1,297,763 $123.0m1.91% 1.91% ReducedShares held: Q3 2025 1.3m, Q4 2025 1.5m, Q1 2026 1.4m, Q2 2026 1.3m -144.9k -144,944 -10.1%
17 PROTAGONIST THERAPEUTICS INC COM PTGX PTGX 981,879 $120.4m1.87% 1.87% ReducedShares held: Q3 2025 1.0m, Q4 2025 1.4m, Q1 2026 1.2m, Q2 2026 981.9k -249.0k -249,000 -20.2%
18 SOLID BIOSCIENCES INC COM NEW SLDB SLDB 11,906,646 $118.9m1.85% 1.85% UnchangedShares held: Q3 2025 11.8m, Q4 2025 11.8m, Q1 2026 11.9m, Q2 2026 11.9m
19 ZYMEWORKS INC COM ZYME ZYME 4,182,953 $109.3m1.70% 1.70% AddedShares held: Q3 2025 2.1m, Q4 2025 3.3m, Q1 2026 3.5m, Q2 2026 4.2m +672.9k +672,875 19.2%
20 TANGO THERAPEUTICS INC COM TNGX TNGX 3,377,000 $105.6m1.64% 1.64% AddedShares held: Q3 2025 0, Q4 2025 513.0k, Q1 2026 808.2k, Q2 2026 3.4m +2.6m +2,568,847 317.9%
21 IMMATICS N.V SHS IMTX IMTX 10,383,456 $105.2m1.63% 1.63% UnchangedShares held: Q3 2025 9.4m, Q4 2025 10.4m, Q1 2026 10.4m, Q2 2026 10.4m
22 NURIX THERAPEUTICS INC COM NRIX NRIX 4,320,422 $104.8m1.63% 1.63% AddedShares held: Q3 2025 1.4m, Q4 2025 3.6m, Q1 2026 3.7m, Q2 2026 4.3m +609.5k +609,545 16.4%
23 BIOCRYST PHARMACEUTICALS INC COM BCRX BCRX 10,308,888 $103.1m1.60% 1.60% AddedShares held: Q3 2025 0, Q4 2025 3.2m, Q1 2026 7.4m, Q2 2026 10.3m +2.9m +2,874,855 38.7%
24 REVOLUTION MEDICINES INC COM RVMD RVMD 527,600 $98.8m1.53% 1.53% AddedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 258.6k, Q2 2026 527.6k +269.0k +269,000 104.0%
25 AVALYN PHARMACEUTICALS INC COM SHS AVLN AVLN 2,675,296 $88.1m1.37% 1.37% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 2.7m
26 DYNE THERAPEUTICS INC COM DYN DYN 2,689,235 $59.7m0.93% 0.93% ReducedShares held: Q3 2025 540.4k, Q4 2025 3.5m, Q1 2026 4.7m, Q2 2026 2.7m -2.0m -1,979,604 -42.4%
27 BIOGEN INC COM BIIB BIIB 276,173 $59.7m0.93% 0.93% NewShares held: Q3 2025 0, Q4 2025 124.0k, Q1 2026 0, Q2 2026 276.2k
28 IMMUNOVANT INC COM IMVT IMVT 1,357,383 $52.3m0.81% 0.81% ReducedShares held: Q3 2025 1.6m, Q4 2025 2.0m, Q1 2026 1.6m, Q2 2026 1.4m -240.0k -240,000 -15.0%
29 UNITEDHEALTH GROUP INC COM UNH UNH 116,806 $48.5m0.75% 0.75% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 116.8k
30 IONIS PHARMACEUTICALS INC COM IONS IONS 566,000 $44.9m0.70% 0.70% AddedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 504.0k, Q2 2026 566.0k +62.0k +62,000 12.3%
31 SUTRO BIOPHARMA INC COM SHS STRO STRO 1,304,846 $43.3m0.67% 0.67% AddedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 715.3k, Q2 2026 1.3m +589.5k +589,539 82.4%
32 ALTO NEUROSCIENCE INC COM SHS ANRO ANRO 1,609,893 $42.5m0.66% 0.66% ReducedShares held: Q3 2025 155.4k, Q4 2025 1.8m, Q1 2026 2.0m, Q2 2026 1.6m -400.0k -400,000 -19.9%
33 JAZZ PHARMACEUTICALS PLC SHS USD JAZZ JAZZ 170,000 $41.0m0.64% 0.64% UnchangedShares held: Q3 2025 0, Q4 2025 170.0k, Q1 2026 170.0k, Q2 2026 170.0k
34 CORVUS PHARMACEUTICALS INC COM CRVS CRVS 2,667,441 $39.9m0.62% 0.62% AddedShares held: Q3 2025 1.4m, Q4 2025 692.4k, Q1 2026 2.3m, Q2 2026 2.7m +375.0k +375,000 16.4%
35 SIONNA THERAPEUTICS INC COM SION SION 905,000 $39.8m0.62% 0.62% AddedShares held: Q3 2025 1.2m, Q4 2025 1.2m, Q1 2026 658.4k, Q2 2026 905.0k +246.6k +246,561 37.5%
36 CYTOMX THERAPEUTICS INC COM CTMX CTMX 10,439,185 $39.1m0.61% 0.61% AddedShares held: Q3 2025 9.7m, Q4 2025 9.7m, Q1 2026 10.1m, Q2 2026 10.4m +340.4k +340,361 3.4%
37 ARTIVION INC COM AORT AORT 1,737,290 $39.0m0.61% 0.61% AddedShares held: Q3 2025 2.0m, Q4 2025 1.7m, Q1 2026 1.6m, Q2 2026 1.7m +100.0k +100,000 6.1%
38 X4 PHARMACEUTICALS INC COM NEW XFOR XFOR 7,933,491 $37.0m0.58% 0.58% AddedShares held: Q3 2025 0, Q4 2025 6.3m, Q1 2026 6.7m, Q2 2026 7.9m +1.2m +1,195,843 17.8%
39 CORCEPT THERAPEUTICS INC COM CORT CORT 398,385 $34.6m0.54% 0.54% AddedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 50.0k, Q2 2026 398.4k +348.4k +348,385 696.8%
40 REPLIGEN CORP COM RGEN RGEN 248,212 $33.9m0.53% 0.53% ReducedShares held: Q3 2025 270.4k, Q4 2025 315.5k, Q1 2026 280.5k, Q2 2026 248.2k -32.3k -32,329 -11.5%
41 ANTERIS TECHNOLOGIES GLOBAL COM AVR AVR 3,425,476 $33.7m0.52% 0.52% UnchangedShares held: Q3 2025 1.7m, Q4 2025 1.7m, Q1 2026 3.4m, Q2 2026 3.4m
42 RAPPORT THERAPEUTICS INC COM RAPP RAPP 773,342 $32.2m0.50% 0.50% AddedShares held: Q3 2025 403.9k, Q4 2025 673.9k, Q1 2026 673.9k, Q2 2026 773.3k +99.4k +99,419 14.8%
43 DAMORA THERAPEUTICS INC COM NEW COM NEW 1,223,000 $31.8m0.49% 0.49% UnchangedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 1.2m, Q2 2026 1.2m
44 CHARLES RIV LABS INTL INC COM CRL CRL 140,000 $31.8m0.49% 0.49% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 140.0k
45 AXSOME THERAPEUTICS INC COM AXSM AXSM 118,450 $29.0m0.45% 0.45% ReducedShares held: Q3 2025 148.9k, Q4 2025 148.9k, Q1 2026 149.9k, Q2 2026 118.5k -31.5k -31,500 -21.0%
46 DBV TECHNOLOGIES S A SPONSORED ADS DBVT DBVT 1,653,350 $27.1m0.42% 0.42% AddedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 964.4k, Q2 2026 1.7m +689.0k +688,959 71.4%
47 IRHYTHM TECHNOLOGIES INC COM IRTC IRTC 223,766 $26.6m0.41% 0.41% AddedShares held: Q3 2025 123.0k, Q4 2025 108.0k, Q1 2026 105.0k, Q2 2026 223.8k +118.7k +118,740 113.1%
48 ADAPTIVE BIOTECHNOLOGIES COR COM ADPT ADPT 1,217,325 $26.1m0.41% 0.41% AddedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 152.5k, Q2 2026 1.2m +1.1m +1,064,825 698.2%
49 SAB BIOTHERAPEUTICS INC COM NEW SABS SABS 6,627,501 $25.8m0.40% 0.40% AddedShares held: Q3 2025 0, Q4 2025 803.2k, Q1 2026 6.4m, Q2 2026 6.6m +195.8k +195,758 3.0%
50 DANAHER CORPORATION COM DHR DHR 130,000 $24.8m0.38% 0.38% NewShares held: Q3 2025 0, Q4 2025 200.0k, Q1 2026 0, Q2 2026 130.0k
51 TENAX THERAPEUTICS INC COM NEW TENX TENX 1,700,000 $24.7m0.38% 0.38% AddedShares held: Q3 2025 0, Q4 2025 439.1k, Q1 2026 1.4m, Q2 2026 1.7m +252.2k +252,218 17.4%
52 NAUTILUS BIOTECHNOLOGY INC COM NAUT NAUT 11,634,211 $21.8m0.34% 0.34% ReducedShares held: Q3 2025 12.6m, Q4 2025 12.6m, Q1 2026 12.6m, Q2 2026 11.6m -960.0k -960,000 -7.6%
53 ORCHESTRA BIOMED HLDGS INC COM OBIO OBIO 5,037,906 $21.7m0.34% 0.34% UnchangedShares held: Q3 2025 5.3m, Q4 2025 5.1m, Q1 2026 5.0m, Q2 2026 5.0m
54 INTUITIVE SURGICAL INC COM NEW ISRG ISRG 51,884 $20.6m0.32% 0.32% ReducedShares held: Q3 2025 52.1k, Q4 2025 87.9k, Q1 2026 85.4k, Q2 2026 51.9k -33.5k -33,535 -39.3%
55 ADLAI NORTYE LTD SPONSORED ADS ANL ANL 1,793,190 $20.6m0.32% 0.32% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 1.8m
56 CONTINEUM THERAPEUTICS INC CL A CTNM CTNM 1,255,592 $20.6m0.32% 0.32% UnchangedShares held: Q3 2025 714.6k, Q4 2025 1.5m, Q1 2026 1.3m, Q2 2026 1.3m
57 NUVECTIS PHARMA INC COM NVCT NVCT 1,000,000 $18.4m0.29% 0.29% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 1.0m
58 PALISADE BIO INC COM PALI PALI 8,425,065 $17.6m0.27% 0.27% ReducedShares held: Q3 2025 0, Q4 2025 12.1m, Q1 2026 8.9m, Q2 2026 8.4m -503.1k -503,084 -5.6%
59 OMADA HEALTH INC COM OMDA OMDA 786,330 $17.3m0.27% 0.27% UnchangedShares held: Q3 2025 2.4m, Q4 2025 2.4m, Q1 2026 786.3k, Q2 2026 786.3k
60 LEONABIO INC COM LONA LONA 1,859,322 $17.1m0.27% 0.27% UnchangedShares held: Q3 2025 540.3k, Q4 2025 1.9m, Q1 2026 1.9m, Q2 2026 1.9m
61 EVOLUS INC COM EOLS EOLS 2,459,285 $17.1m0.27% 0.27% AddedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 1.3m, Q2 2026 2.5m +1.2m +1,172,423 91.1%
62 INVIVYD INC COM IVVD IVVD 18,490,636 $16.1m0.25% 0.25% ReducedShares held: Q3 2025 0, Q4 2025 21.8m, Q1 2026 20.9m, Q2 2026 18.5m -2.4m -2,368,667 -11.4%
63 CELCUITY INC NOTE 2.750% 8/0 · principal CELC 2.75 08.01.31 · principal CELC 2.75 08.01.31 6,500,000 $14.6m0.23% 0.23% UnchangedPrincipal held: Q3 2025 6.5m, Q4 2025 6.5m, Q1 2026 6.5m, Q2 2026 6.5m
64 MIRUM PHARMACEUTICALS INC COM MIRM MIRM 115,391 $13.5m0.21% 0.21% NewShares held: Q3 2025 0, Q4 2025 259.5k, Q1 2026 0, Q2 2026 115.4k
65 SURROZEN INC COM NEW SRZN SRZN 503,985 $13.1m0.20% 0.20% AddedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 229.4k, Q2 2026 504.0k +274.6k +274,592 119.7%
66 BETA BIONICS INC COM BBNX BBNX 832,944 $13.1m0.20% 0.20% ReducedShares held: Q3 2025 277.9k, Q4 2025 602.9k, Q1 2026 842.9k, Q2 2026 832.9k -10.0k -10,000 -1.2%
67 AXOGEN INC COM AXGN AXGN 247,312 $11.4m0.18% 0.18% ReducedShares held: Q3 2025 0, Q4 2025 784.1k, Q1 2026 697.3k, Q2 2026 247.3k -450.0k -450,000 -64.5%
68 OSCAR HEALTH INC CL A OSCR OSCR 400,000 $11.4m0.18% 0.18% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 400.0k
69 OCULIS HOLDING AG ORDINARY SHARES OCS OCS 808,827 $11.2m0.17% 0.17% AddedShares held: Q3 2025 0, Q4 2025 493.8k, Q1 2026 493.8k, Q2 2026 808.8k +315.0k +315,000 63.8%
70 SEAPORT THERAPEUTICS INC COMMON STOCK SPTX SPTX 500,000 $10.9m0.17% 0.17% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 500.0k
71 VIRIDIAN THERAPEUTICS INC COM VRDN VRDN 581,980 $10.7m0.17% 0.17% ReducedShares held: Q3 2025 1.5m, Q4 2025 3.0m, Q1 2026 1.2m, Q2 2026 582.0k -588.8k -588,849 -50.3%
72 BOSTON SCIENTIFIC CORP COM BSX BSX 250,000 $10.7m0.17% 0.17% NewShares held: Q3 2025 310.0k, Q4 2025 979.0k, Q1 2026 0, Q2 2026 250.0k
73 BILLIONTOONE INC CL A BLLN BLLN 86,812 $10.4m0.16% 0.16% ReducedShares held: Q3 2025 0, Q4 2025 72.8k, Q1 2026 91.8k, Q2 2026 86.8k -5.0k -5,000 -5.5%
74 ABIVAX SA SPONSORED ADS ABVX ABVX 74,000 $9.9m0.15% 0.15% ReducedShares held: Q3 2025 388.6k, Q4 2025 458.3k, Q1 2026 328.9k, Q2 2026 74.0k -254.9k -254,884 -77.5%
75 NATERA INC COM NTRA NTRA 34,689 $9.4m0.15% 0.15% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 34.7k
76 ENGENE THERAPEUTICS INC COM ENGN ENGN 4,822,169 $8.3m0.13% 0.13% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 4.8m
77 RESEARCH ALLIANCE CORP III ORD SHS CL A RACC RACC 750,000 $8.0m0.12% 0.12% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 750.0k
78 AGOMAB THERAPEUTICS NV SPONSORED ADS AGMB AGMB 600,000 $7.8m0.12% 0.12% UnchangedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 600.0k, Q2 2026 600.0k
79 CULLINAN THERAPEUTICS INC COM CGEM CGEM 426,478 $7.8m0.12% 0.12% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 426.5k
80 UNIQURE NV SHS QURE QURE 168,000 $7.7m0.12% 0.12% NewShares held: Q3 2025 20.0k, Q4 2025 0, Q1 2026 0, Q2 2026 168.0k
81 MOBIA MED INC COMMON STOCK MOBI MOBI 523,654 $7.0m0.11% 0.11% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 523.7k
82 ADAGIO MED HLDGS INC COM ADGM ADGM 9,876,586 $6.4m0.10% 0.10% AddedShares held: Q3 2025 9.9m, Q4 2025 9.9m, Q1 2026 9.9m, Q2 2026 9.9m +10 +10 0.0%
83 GUARDANT HEALTH INC COM GH GH 41,327 $6.2m0.10% 0.10% ReducedShares held: Q3 2025 0, Q4 2025 160.0k, Q1 2026 300.0k, Q2 2026 41.3k -258.7k -258,673 -86.2%
84 PHATHOM PHARMACEUTICALS INC COM PHAT PHAT 532,000 $5.8m0.09% 0.09% ReducedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 925.0k, Q2 2026 532.0k -393.0k -393,000 -42.5%
85 OUTLOOK THERAPEUTICS INC COM OTLK OTLK 3,139,216 $5.0m0.08% 0.08% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 3.1m
86 COGENT BIOSCIENCES INC COM COGT COGT 121,082 $4.7m0.07% 0.07% UnchangedShares held: Q3 2025 0, Q4 2025 121.1k, Q1 2026 121.1k, Q2 2026 121.1k
87 EDESA BIOTECH INC COM NEW EDSA EDSA 563,239 $4.6m0.07% 0.07% UnchangedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 563.2k, Q2 2026 563.2k
88 AVALO THERAPEUTICS INC COM NEW AVTX AVTX 219,813 $4.1m0.06% 0.06% AddedShares held: Q3 2025 139.7k, Q4 2025 139.7k, Q1 2026 139.7k, Q2 2026 219.8k +80.1k +80,146 57.4%
89 TWIST BIOSCIENCE CORP COM TWST TWST 36,812 $3.8m0.06% 0.06% ReducedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 150.0k, Q2 2026 36.8k -113.2k -113,188 -75.5%
90 CRESCENT BIOPHARMA INC. COM CBIO CBIO 206,942 $3.7m0.06% 0.06% UnchangedShares held: Q3 2025 453.7k, Q4 2025 453.7k, Q1 2026 206.9k, Q2 2026 206.9k
91 XERIS BIOPHARMA HOLDINGS INC COM XERS XERS 467,013 $3.7m0.06% 0.06% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 467.0k
92 OUTSET MED INC COM NEW OM OM 833,333 $3.6m0.06% 0.06% UnchangedShares held: Q3 2025 833.3k, Q4 2025 833.3k, Q1 2026 833.3k, Q2 2026 833.3k
93 BIODESIX INC COM BDSX BDSX 108,694 $2.5m0.04% 0.04% NewShares held: Q3 2025 108.7k, Q4 2025 108.7k, Q1 2026 0, Q2 2026 108.7k
94 REVOLUTION MEDICINES INC *W EXP 12/17/202 RVMDW RVMDW 250,000 $2.3m0.04% 0.04% UnchangedShares held: Q3 2025 250.0k, Q4 2025 250.0k, Q1 2026 250.0k, Q2 2026 250.0k
95 CONNECT BIOPHARMA HLDGS LTD SHS CNTB CNTB 792,696 $1.9m0.03% 0.03% UnchangedShares held: Q3 2025 0, Q4 2025 792.7k, Q1 2026 792.7k, Q2 2026 792.7k
96 KIORA PHARMACEUTICALS INC COM KPRX KPRX 438,471 $1.2m0.02% 0.02% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 438.5k
97 MEDLINE INC COM CL A MDLN MDLN 28,000 $1.1m0.02% 0.02% UnchangedShares held: Q3 2025 0, Q4 2025 28.0k, Q1 2026 28.0k, Q2 2026 28.0k
98 ADMA BIOLOGICS INC COM ADMA ADMA 113,765 $952.2k0.01% 0.01% ReducedShares held: Q3 2025 1.2m, Q4 2025 883.5k, Q1 2026 467.2k, Q2 2026 113.8k -353.5k -353,468 -75.7%
99 CUMBERLAND PHARMACEUTICALS I COM CPIX CPIX 96,982 $628.4k0.01% 0.01% ReducedShares held: Q3 2025 0, Q4 2025 341.1k, Q1 2026 197.0k, Q2 2026 97.0k -100.0k -99,996 -50.8%
100 EXAGEN INC COM XGN XGN 114,893 $534.3k0.01% 0.01% UnchangedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 114.9k, Q2 2026 114.9k

Sold out since Q1 2026

SecurityTickerShares held beforeValue then
ASCENDIS PHARMA A/S 1,531,421 $350.3m1.5m shares
CENTESSA PHARMACEUTICALS PLC 5,258,903 $208.9m5.3m shares
ENGENE HOLDINGS INC 5,827,506 $39.7m5.8m shares
DAY ONE BIOPHARMACEUTICALS I 1,755,799 $37.6m1.8m shares
BRIGHT MINDS BIOSCIENCES INC DRUG DRUG 377,544 $27.5m377.5k shares
BELITE BIO INC BLTE BLTE 151,979 $24.2m152.0k shares
EVOMMUNE INC EVMN EVMN 448,350 $10.3m448.4k shares
NEUMORA THERAPEUTICS INC. NMRA NMRA 5,104,097 $10.0m5.1m shares
NEUROCRINE BIOSCIENCES INC NBIX NBIX 65,050 $8.6m65.0k shares
OPUS GENETICS INC IRD IRD 1,835,842 $8.4m1.8m shares
INHIBIKASE THERAPEUTICS INC IKT IKT 2,315,000 $3.9m2.3m shares
APELLIS PHARMACEUTICALS INC APLS APLS 80,956 $3.3m81.0k shares
PALATIN TECHNOLOGIES INC PTN PTN 61,945 $1.1m61.9k shares

Options (notional value)

UnderlyingTickerTypeShares controlled NotionalChange
MODERNA INC MRNA · Put MRNAPut 1,000,000 $70.0m1.0m shares Unchanged
SPDR SER TR XBI · Put XBIPut 300,000 $47.5m300.0k shares New
EYEPOINT PHARMACEUTICALS INC EYPT · Put EYPTPut 2,000,000 $28.6m2.0m shares New
CAPRICOR THERAPEUTICS INC CAPR · Call CAPRCall 1,000,000 $24.1m1.0m shares New
SELLAS LIFE SCIENCES GROUP I SLS · Put SLSPut 1,500,000 $22.1m1.5m shares New
NEWAMSTERDAM PHARMA COMPANY NAMS · Put NAMSPut 500,000 $16.9m500.0k shares New
CAPRICOR THERAPEUTICS INC CAPR · Put CAPRPut 500,000 $12.0m500.0k shares New

Stakes above 5%

Companies where this manager has reported owning more than 5% of a class of shares, on Schedule 13D (may seek influence) or 13G (passive): its latest filing for each, from 19 Dec 2024 on. The largest 25 of 38.

CompanyTickerStakeChange ScheduleLast filed
ADAGIO MED HLDGS INC ADGM · 13G · filed 2026-05-15 ADGM 55.4%≈ $8.8m -2.1 pts 13G 2026-05-15
LEONABIO INC LONA · 13D · filed 2026-10-26 LONA 20.0%≈ $17.4m no change 13D 2026-10-26
LYRA THERAPEUTICS INC LYRA · 13D · filed 2025-08-14 LYRA 15.6% 13D 2025-08-14
MEIRAGTX HLDGS PLC MGTX · 13D · filed 2026-04-24 MGTX 12.6%≈ $158.6m -0.3 pts 13D 2026-04-24
SOLID BIOSCIENCES INC SLDB · 13D · filed 2026-08-14 SLDB 11.2%≈ $120.3m -1.7 pts 13D 2026-08-14
PERCEPTIVE CAP SOLUTIONS COR FRNM · 13G · filed 2026-07-23 FRNM 10.1% new 13G 2026-07-23
INHIBRX BIOSCIENCES INC INBX · 13G · filed 2026-08-14 INBX 10.0%≈ $141.1m no change 13G 2026-08-14
ALTO NEUROSCIENCE INC ANRO · 13G · filed 2026-08-14 ANRO 10.0%≈ $110.2m no change 13G 2026-08-14
OPUS GENETICS INC IRD · 13G · filed 2026-08-14 IRD 10.0%≈ $37.6m no change 13G 2026-08-14
ENGENE HOLDINGS INC 13G · filed 2026-08-14 10.0% no change 13G 2026-08-14
KIORA PHARMACEUTICALS INC KPRX · 13G · filed 2026-08-10 KPRX 10.0%≈ $1.2m new 13G 2026-08-10
ENVVENO MEDICAL CORPORATION 13G · filed 2026-02-17 10.0% 13G 2026-02-17
ORCHESTRA BIOMED HLDGS INC OBIO · 13G · filed 2025-11-14 OBIO 10.0%≈ $24.5m 13G 2025-11-14
TRINITY BIOTECH PLC 13D · filed 2026-05-04 9.9% no change 13D 2026-05-04
OUTSET MED INC OM · 13G · filed 2025-02-28 OM 9.5% new 13G 2025-02-28
NAUTILUS BIOTECHNOLOGY INC NAUT · 13D · filed 2026-08-14 NAUT 9.1%≈ $21.8m -1.0 pts 13D 2026-08-14
KARDIGAN INC KARD · 13D · filed 2026-10-01 KARD 8.8%≈ $196.9m -0.1 pts 13D 2026-10-01
QUINCE THERAPEUTICS INC IRLA · 13G · filed 2026-10-14 IRLA 8.4%≈ $1.7m new 13G 2026-10-14
RESEARCH ALLIANCE CORP III RACC · 13G · filed 2026-05-28 RACC 8.2%≈ $8.0m new 13G 2026-05-28
X4 PHARMACEUTICALS INC XFOR · 13G · filed 2026-08-14 XFOR 8.1%≈ $37.8m +0.8 pts 13G 2026-08-14
SUTRO BIOPHARMA INC STRO · 13G · filed 2026-08-14 STRO 7.9%≈ $43.3m +2.5 pts 13G 2026-08-14
PALISADE BIO INC PALI · 13G · filed 2026-05-15 PALI 7.9%≈ $29.5m -2.1 pts 13G 2026-05-15
IMMATICS N.V IMTX · 13D · filed 2026-08-27 IMTX 7.6%≈ $113.5m 13D 2026-08-27
AMYLYX PHARMACEUTICALS INC AMLX · 13G · filed 2026-05-15 AMLX 7.5%≈ $148.8m -0.7 pts 13G 2026-05-15
SAB BIOTHERAPEUTICS INC SABS · 13G · filed 2026-08-14 SABS 7.3%≈ $25.8m -1.1 pts 13G 2026-08-14

Trades reported as a company insider since 1 Apr 2026

Owning 10% or more of a company, or having someone on its board, makes this manager an insider there: it reports its trades in that company's shares on Form 4 within two business days. Open-market and private purchases and sales only.

DateCompanyTickerTradeShares ValueTheir holding
2026-08-26 IMMATICS N.V Director · See Footnote IMTX Bought 863,060 $7.5m863.1k shares +8%